We are live on ! Find out more
ONXX

ONYX PHARMACEUTICALS INC
ONXX

Delisted

ONXX was delisted on the 30th of September, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in ONYX PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 257 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 258 → 0 (-258)

100% less funds holding in top 10

Funds holding in top 10: 46 → 0 (-46)

100% less capital invested

Capital invested by funds: $7.38B → $0 (-$7.38B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 257

Holders
–
Holders Change
-258
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-46
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
257
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$512M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$421M
3
DKCM
Davidson Kempner Capital Management
New York
-$393M
4
HI
HBK Investments
Texas
-$339M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$259M
Name Holding Trade Value Shares
Change 		Change in
Stake
MTB
101
Mizuho Trust & Banking
Japan
– -$8.33M -95,898 Closed
CCM
102
Century Capital Management
Massachusetts
– -$11.8M -95,031 Closed
PCM
103
Pentwater Capital Management
Florida
– -$11.7M -93,878 Closed
BCM
104
Bluefin Capital Management
New York
– -$11.2M -89,882 Closed
HM
105
Harvest Management
New York
– -$10.8M -86,600 Closed
BJ
106
BlackRock Japan
Japan
– -$10.8M -86,477 Closed
CC
107
Coastland Capital
California
– -$10.6M -85,188 Closed
Swiss National Bank
108
Swiss National Bank
Switzerland
– -$9.82M -78,800 Closed
LCS
109
Levin Capital Strategies
New York
– -$9.62M -77,133 Closed
Ameriprise
110
Ameriprise
Minnesota
– -$9.51M -76,262 Closed
RhumbLine Advisers
111
RhumbLine Advisers
Massachusetts
– -$9.19M -73,726 Closed
Credit Agricole
112
Credit Agricole
France
– -$9.18M -73,622 Closed
Retirement Systems of Alabama
113
Retirement Systems of Alabama
Alabama
– -$8.56M -68,700 Closed
HS
114
HighVista Strategies
Massachusetts
– -$8.55M -68,537 Closed
PI
115
PineBridge Investments
New York
– -$8.49M -68,100 Closed
BPGAM
116
BTG Pactual Global Asset Management
Bermuda
– -$8.07M -64,730 Closed
Fuller & Thaler Asset Management
117
Fuller & Thaler Asset Management
California
– -$8.04M -64,450 Closed
Nomura Holdings
118
Nomura Holdings
Japan
– -$7.86M -63,085 Closed
BCM
119
BBT Capital Management
Texas
– -$7.48M -60,000 Closed
Invesco
120
Invesco
Georgia
– -$7.46M -59,807 Closed
AllianceBernstein
121
AllianceBernstein
Tennessee
– -$7.28M -58,370 Closed
MAA
122
Managed Account Advisors
New Jersey
– -$6.91M -55,434 Closed
GLAM
123
Gardner Lewis Asset Management
Pennsylvania
– -$6.77M -54,300 Closed
PAMU
124
Pictet Asset Management (UK)
United Kingdom
– -$6.76M -54,200 Closed
Principal Financial Group
125
Principal Financial Group
Iowa
– -$6.52M -52,270 Closed
3 4
5
6 7

ONXX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q4 2013, worth a combined $0 — down 100% from $7.38B a quarter earlier.

Sellers outnumbered buyers: 257 funds closed out of ONXX and 0 opened new positions — a net loss of 257 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Adage Capital Partners, exiting entirely with an estimated $512M sold.

  • 0 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q4 2013, down from 258 in Q3 2013.
  • Funds reported $0 of ONYX PHARMACEUTICALS INC stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ONYX PHARMACEUTICALS INC positions in Q4 2013 and 257 closed out, a net change of -257 holders.
  • The largest ONYX PHARMACEUTICALS INC seller in Q4 2013 was Adage Capital Partners, an estimated $512M sold.

Based on aggregated 13F filings for Q4 2013.